Tsubota A, Akiyama M, Sakai K, et al: Congenital ichthyosiform erythroderma
mimicking ichthyosis bullosa of Siemens.
Staging and prognosis of mycosis fungoides * Stage Skin disease Adenopathy IA Patch/plaque (<10% BSA) - IB Patch/plaque (>10% BSA) - IIA Patches or plaques + IIB Tumors [+ or -] III Generalized erythroderma
[+ or -] IVA Patch/plaque, tumors, or erythroderma
[+ or -] IVB Patch/plaque, tumors, or erythroderma
[+ or -] Lymph node Visceral Stage pathology involvement IA - - IB - - IIA - - IIB - - III - - IVA + - IVB + + Survival at Stage 10 years IA 100% IB 100% IIA 64% IIB 64% III 45% IVA Poor IVB Poor * From reference 11.
Keratotic spines and Lesions appeared on the dorsa of the hands pits (15) and fingers and on the posterior neck of a 6-year-old boy who also had generalized erythroderma
It is interesting that our patient developed ocular symptoms 2 months after experiencing erythroderma
The compound, known as Glylorin(TM), entered phase III clinical trials in January 1996 for nonbullous congenital ichthyosiform erythroderma
(n-CIE), and also is expected to be evaluated in the treatment of other less severe forms of the disease.
A diffuse macular erythroderma
mimicking sunburn rash was noted.
Nasdaq: CLGY; Warrants: CLGYW) announced today it had commenced Phase III clinical trials on Glylorin(TM) for the treatment of non-bullous congenital ichthyosiform erythroderma
, a congenital skin disease which is a subtype of congenital primary ichthyosis.
SAHA was shown to reduce the tumor burden and improve pruritus in CTCL patients, especially those with erythroderma
and Sezary Syndrome.
A 63-year-old white woman had generalized erythroderma
in the spring of 1999.
today announced the completion of a Phase II dose-ranging study of Glylorin(TM) (monolaurin) in patients with congenital ichthyosis erythroderma
When large numbers of the tumor cells are found circulating in the blood along with erythroderma
and lymphadenopathy, the condition is called the Sezary syndrome.
85] Cutaneous manifestations of the leukemias are varied, and additional skin findings include hemorrhagic lesions, generalized pruritus, exfoliative erythroderma
, pyoderma gangrenosum, urticaria, erythema multiforme, erythema nodosum, panniculitis, hyperpigmentation, and morbilliform eruptions.